Articles tagged with Growth Hormone
A new study from Nationwide Children's Hospital found that adenotonsillectomy is effective in most children with Prader-Willi syndrome who have mild to moderate obstructive sleep apnea, but may not be curative for those with severe forms. The procedure helped normalize sleep patterns in 89% of patients.
A randomized clinical trial found that treatment with growth hormone-releasing hormone improved cognitive function in both healthy older adults and those with mild cognitive impairment. The study also showed increased insulin-like growth factor 1 levels, which may play a role in brain health.
A recent study published in the Journal of Pediatrics found that babies born to overweight or obese mothers gained less weight and grew less in length than those born to normal-weight mothers. This delayed growth may be attributed to inflammation and an underdeveloped pituitary gland, which plays a crucial role in fetal development.
Researchers at Michigan State University have found a way for plants to balance their growth and defense mechanisms, enabling them to continue growing while protecting themselves from harm. This discovery could help improve crop yields by allowing plants to prioritize growth over defense.
Scientists have discovered that stimulating brain hormones may help prevent a deadly second wave of death in patients with pneumonia. The research found that an agonist mimics the action of growth hormone-releasing hormone, which protects the air sacs and capillaries from fluid and cell damage.
A six-month growth hormone replacement study found increased bone formation, muscle mass, and decreased abdominal fat in abdominally obese women. The results suggest growth hormone as a potential treatment for postmenopausal osteoporosis.
Post-menopausal women with high hormone levels, including estrogen and testosterone, have a higher risk of breast cancer. Researchers found that each additional elevated hormone level increases risk by 16%. The study suggests that models assessing breast cancer risk could be improved by considering multiple hormone levels.
Researchers found that growth hormone stimulates cell proliferation in zebrafish inner ears, particularly those of the utricle vestibular organ involved in balance. This discovery may lead to new treatments for human hair cell loss and ear injuries.
Researchers developed a stem cell treatment enriched with insulin-like growth factor-I (IGF-I) to mend non-healing bone fractures. The study showed that the treated cells became bone cells and helped repair fractures in animal models.
Scientists have discovered that high levels of insulin-like growth factor I (IGF-I) are associated with better long-term recovery after a stroke. The study found that patients who exercised more actively, with physiotherapy and physical exercise, demonstrated better recovery after a stroke.
A new study published in the New England Journal of Medicine found that treating girls with Turner syndrome with low doses of estrogen and growth hormone significantly increased their adult height. The treatment also showed modest synergy between growth hormone and low-dose estrogen in promoting growth.
A decades-long study demonstrates that low doses of estrogen combined with growth hormone in prepubescent girls with Turner syndrome has a synergistic effect on growth, increasing their height and improving cognitive functioning. The treatment also shows benefits for psychosocial development.
UCSF researchers have discovered a crucial hormone pathway that contributes to the development of fatty liver disease. By disrupting this pathway, they found that fat accumulation in the liver can occur even without alcohol consumption. The study's findings may lead to the development of new therapeutic drugs targeting this pathway.
A 22-year study found no cases of diabetes and only one non-lethal case of cancer in individuals with Laron syndrome, a growth-stunting mutation. In contrast, relatives without such mutations had higher rates of diabetes and cancer. The study suggests that blocking growth hormone activity may be protective against these diseases.
A new study reveals that 12% of American male weightlifters aged 18-40 use illicit HGH, often associated with AAS and street drug abuse. The long-term risks of high-dose HGH use are little studied but may include cardiac, endocrine, and respiratory effects.
Researchers have discovered a compound that reverses some signs of aging, including oxidative stress and cognitive impairment. The study found that MZ-5-156 had positive effects on life span, telomerase activity, and tumor activity, while decreasing cancer incidence.
A new study found that infants with cystic fibrosis have reduced IGF1 levels compared to healthy infants, suggesting that IGF1 deficits begin early in the course of CF disease. This could lead to new therapies for growth defects in people with CF.
Researchers at Johns Hopkins University School of Medicine used mice engineered to lack specific molecules to show that growth hormone controls skeletal muscle development via IGF-1, but not nutrient uptake. This study provides insights into the use of growth hormone or analogs for promoting muscle development and reducing muscle loss.
Researchers have discovered that growth hormone controls skeletal muscle development through IGF-1, whereas its effect on nutrient uptake is independent of IGF-1. In contrast, aldosterone promotes vascular injury by inducing expression of the protein PGF in mouse and human blood vessel walls.
A study by the American Society of Nephrology found that growth hormone therapy improved growth and bone mineral density in infants with chronic kidney failure. Infants treated with growth hormone grew an average of 5.7 inches, while those without treatment grew only 3.7 inches.
Researchers found growth hormone increases sprint capacity by 4-5% in athletes, but no effect on muscle mass. Athletes experienced swelling and joint pain with growth hormone use.
A leading medical authority criticizes the use of anti-aging hormones, citing little to no benefit and high risks. Dr. Thomas T. Perls advocates for caution and proper guidance for patients seeking healthy aging solutions.
A new study found that older men with high levels of IGF-I are at increased risk of cancer death, independent of age and lifestyle. The research suggests IGF-I may have potential importance as a biomarker for prognostic testing.
A new study with Brazilian dwarves suggests human growth hormone deficiency has no effect on normal lifespan. Contrary to previous claims, HGH levels do not seem to positively or negatively impact lifespan.
Researchers found that chronic exposure to low doses of BPA impairs the growth and function of adult reproductive cells in mice. This can lead to fertility issues due to impaired ovulation and reduced production of essential sex hormones.
Researchers at the University of Nottingham have identified gibberellin as a hormone controlling plant root growth by regulating cell proliferation and expansion rates. The study highlights the importance of understanding hormone regulation in plant biology for improving crop yields.
A new study found that inhaled growth hormone is well-tolerated by children with growth hormone deficiency and can safely deliver the medication to their bloodstream over a one-week period. The inhaler was preferred over traditional injections, which can be painful and difficult to administer.
Versartis has presented positive preclinical data on its two product candidates, VRS-317 and VRS-826, which have the potential to extend half-life of drugs. The company's compounds have shown in vivo potency equal to daily hGH and sustained plasma levels without toxicity.
Researchers explore health outcomes of IBD, finding increased radiation exposure among patients, especially those with Crohn's disease. Growth hormone therapy shows promise in reducing symptoms and improving disease activity in pediatric CD patients.
A new study published in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism found that growth hormone treatment after weight loss surgery reduces lean body mass and skeletal muscle mass losses. Researchers discovered that short-term growth hormone treatment during a standardized diet and exercise program increased l...
A new study published in Neurology found that growth hormone insulin-like growth factor-1 (IGF-1) does not slow the progression of weakness in amyotrophic lateral sclerosis (ALS). The two-year study involved 330 people with ALS and found no difference in muscle strength between those taking IGF-1 and placebo, as well as no differences ...
A new study published in Neurology found that a growth hormone drug, MK-677, did not slow the symptoms of Alzheimer's disease in humans. The study involved 416 participants with mild to moderate Alzheimer's disease and showed no significant impact on disease progression despite increased levels of insulin-like growth factor-1.
A new study published in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism found that dose-dependent growth hormone treatment increased final height in children with short stature who are not GH deficient. Children from parents of normal height responded better to treatment than those from short parents.
A daily oral dose of MK-677 increased muscle mass in healthy older adults by restoring 20% of lost muscle mass associated with aging. The study shows promise for a treatment that could help prevent age-related frailty and maintain independence as seniors age.
A new study found that stimulating growth hormone release in healthy older adults increased lean muscle mass, but not thigh muscle area. Another study revealed a decrease in cardiogenic shock rates among patients with acute coronary syndromes, possibly linked to improved angioplasty treatments
A recent study by Ohio University researchers found that women's muscles require longer and more intensive rehabilitation after bed rest and cast immobilization. Women lose around 30% less muscle strength within one week of cast removal compared to men, suggesting different rates of muscular strength-building may be the cause.
Researchers identified genes controlling rhythmic plant growth, enabling bursts of growth at night and increasing competitiveness in shaded environments. These findings could lead to designing crops that grow faster and produce more food than current varieties.
Researchers at Washington University School of Medicine discovered a gene's effect on height that may change tumor disorder treatment for patients with neurofibromatosis type 1. The study found that the NF1 gene affects stature through a different pathway than previously focused on for cancer treatment.
A study found that low-dose growth hormone treatment reduced visceral adipose tissue and improved blood pressure in HIV-infected patients with abdominal obesity. However, it also increased glucose levels during glucose tolerance testing, highlighting the need for caution when using growth hormone therapy in this population.
A low-dose growth hormone treatment reduced abdominal fat deposits and improved blood pressure and triglyceride levels in HIV patients with lipodystrophy. However, growth hormone treatment appeared to increase blood glucose levels, particularly in those with impaired glucose tolerance.
Researchers at UT Southwestern Medical Center discovered that FGF21 blocks the effects of growth hormone, potentially extending life span. The study found genetically altered mice with resistance to growth hormone produced greater amounts of growth hormone.
A new study finds that high levels of FGF21 hormone cause mice to become resistant to growth hormone, stunting their growth. This discovery provides insights into the physiological role of FGF21 in energy conservation during food deprivation.
Researchers at the University of Granada have developed a method to drastically reduce the wait time for new teeth implants by using growth hormone. The process enables faster bone regeneration and integration with dental implants, improving patients' quality of life.
The article highlights the alarming growth of the human growth hormone (hGH) industry, worth $2 billion annually. Deceptive marketing by anti-aging clinics and compounding pharmacies has led to increased distribution of hGH for non-approved uses, posing significant health risks, including cancer.
A new study by The Endocrine Society found that male recreational athletes who believed they were using growth hormone experienced improved athletic performance, even when given a placebo. In contrast, female athletes showed little benefit from the placebo effect.
The illegal distribution of growth hormone (hGH) by distributors has grown worse despite overwhelming evidence of its risks and dangers. Researchers call for measures to address the issue, including accurate public information and revocation of organizations promoting hGH use.
Researchers have pinpointed four proteins - apoA1, transthyretin, clusterin and albumin - that react strongly to bovine growth hormone, potentially serving as biomarkers for growth hormone activity in humans. The discovery could offer a wider testing window for detecting recombinant human growth hormone misuse.
Researchers have identified potential biomarkers for growth hormone that could aid in detecting doping in athletes. Several proteins increased or decreased in the blood of mice treated with growth hormone, offering new possibilities for testing.
A study by Children's Hospital of Philadelphia found that in the US and Asia, boys are twice as likely to receive growth hormone treatment for short stature compared to girls. The gender disparity is smaller in Europe and Australia, suggesting cultural biases towards male height in some countries.
Researchers at NC State University have identified a small group of genes responsible for regulating hormone production in plants. The study found that the TAA1 gene is essential for auxin synthesis and that its disruption can lead to reduced auxin levels, affecting plant growth and development.
A study found that genetic variations in the MBL2 protein are associated with more severe clinical symptoms of cystic fibrosis. In contrast, daily administration of growth hormone increased CD4+ T cell numbers in HIV-1 infected individuals, potentially treating conditions where CD4+ T cell function is impaired.
Researchers at Vanderbilt University developed an RNA interference therapy that corrects a genetic disorder causing growth deficiency in mice. The therapy successfully restored normal growth and function to the pituitary gland, which produces growth hormone.
Researchers developed a mathematical model predicting optimal growth hormone dose for children with abnormal growth, showing improved predictive accuracy. The model uses data on birth weight, height before and during treatment, and blood hormone levels to determine individual response.
A new investigational drug, tesamorelin, significantly improved symptoms of HIV lipodystrophy by reducing deep abdominal fat deposits and improving lipid abnormalities. Participants reported significant improvements in body image and reduced distress.
Scientists at the University of Sheffield have developed a long-acting growth hormone that can promote growth over ten days with just one injection. This technology could reduce the need for frequent injections in children and adults with growth hormone disorders.
A case study reports a 36-year-old bodybuilder developing diabetes after using growth hormone and anabolic steroids for extended periods. Regular blood sugar checks are urged for individuals taking high doses of growth hormone to prevent similar cases.
A review found that growth hormone had minimal effects on body composition but increased rates of unhealthy side effects, diabetes, and adverse events. The use of GH for anti-aging in healthy adults is not recommended due to the lack of evidence and potential risks.
A review of human growth hormone use in healthy elderly people found minimal benefits and high adverse events. Narcotics are often prescribed for chronic back pain but have poor efficacy data and high abuse rates. Meanwhile, highly active antiretroviral therapy (HAART) has improved HIV survival rates among those diagnosed since 2000.
A Stanford study systematically reviewed medical literature on growth hormone therapy for the elderly, concluding that it has minimal to no benefit and potential adverse side effects. The research found modest effects on body composition but no impact on clinically important outcomes such as bone density or cholesterol levels.
A study published in Nature found that mice lacking a critical gene for repairing damaged DNA grow old rapidly and exhibit physical and genetic changes similar to those of normal-aged mice. The researchers discovered a new type of human progeria, a rare inherited disease characterized by accelerated aging.